Australian-born founder who solved his own decade-long misdiagnosis at 18 via '10X doctor.' Founded Superpower 3 years ago to democratize frontier medicine via AI-first health platform. Raised $40M Series A, growing thousands of members/month. Building digital twin, AI clinical reasoning, and full-stack action layer.
no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY
Superpower builds AI-first health platform with 100+ biomarker testing ($199), digital twin, AI clinical reasoning (ensemble models + proprietary clinical canon), and action layer (supplements, pharmaceuticals, peptides). Growing via word-of-mouth with 93% members rating AI report far better than primary care. Planning Series B mid-2025.
Future GLP-1 generations will be patented by Eli Lilly and Novo Nordisk with defensible IP, making current compounding bets risky long-term despite short-term viability. The next wave of GLP-1s will have improved delivery, absorption, duration and side effect profiles protected by patents.
Hims follows a CPG/e-commerce path (fastest to revenue/gross profit) but lacks lifestyle brand and tech layer; Superpower takes product-first tech approach with stronger retention and platform dynamics. The winner depends on whether incumbent gets innovation before startup gets distribution.